Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 5,634.00
+1.00 (0.02%)
Aug 21, 2026, 3:30 PM JST
Kobayashi Pharmaceutical Market Cap
Kobayashi Pharmaceutical has a market cap or net worth of 418.82 billion as of August 21, 2026. Its market cap has increased by 2.44% in one year.
Market Cap
418.82B
Enterprise Value
362.23B
Revenue
167.47B
Ranking
n/a
PE Ratio
257.74
Stock Price
5,634.00
ChartMarket Cap Chart
Since August 17, 1999, Kobayashi Pharmaceutical's market cap has increased from 245.70B to 418.82B, an increase of 70.46%. That is a compound annual growth rate of 1.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 418.82B | 3.79% |
| Dec 30, 2025 | 403.51B | -12.87% |
| Dec 30, 2024 | 463.13B | -8.08% |
| Dec 29, 2023 | 503.84B | -22.52% |
| Dec 30, 2022 | 650.29B | -7.68% |
| Dec 30, 2021 | 704.43B | -28.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shiseido Company | 1.47T |
| Rohto Pharmaceutical | 647.73B |
| Lion Corporation | 528.29B |
| MTG Co., Ltd. | 340.04B |
| KOSE Holdings | 329.38B |
| Pola Orbis Holdings | 311.12B |
| Pigeon | 257.48B |
| Noevir Holdings | 166.34B |